179 related articles for article (PubMed ID: 36474126)
41. Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.
Okuno Y; Hoshino A; Muramatsu H; Kawashima N; Wang X; Yoshida K; Wada T; Gunji M; Toma T; Kato T; Shiraishi Y; Iwata A; Hori T; Kitoh T; Chiba K; Tanaka H; Sanada M; Takahashi Y; Nonoyama S; Ito M; Miyano S; Ogawa S; Kojima S; Kanegane H
J Clin Immunol; 2015 Oct; 35(7):610-4. PubMed ID: 26407811
[TBL] [Abstract][Full Text] [Related]
42. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus.
Li FY; Chaigne-Delalande B; Su H; Uzel G; Matthews H; Lenardo MJ
Blood; 2014 Apr; 123(14):2148-52. PubMed ID: 24550228
[TBL] [Abstract][Full Text] [Related]
43. Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia.
Nemoto M; Hattori H; Maeda N; Akita N; Muramatsu H; Moritani S; Kawasaki T; Maejima M; Ode H; Hachiya A; Sugiura W; Yokomaku Y; Horibe K; Iwatani Y
Sci Rep; 2018 May; 8(1):6956. PubMed ID: 29725107
[TBL] [Abstract][Full Text] [Related]
44. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
Lin N; Ku W; Song Y; Zhu J; Lu Z
Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
[TBL] [Abstract][Full Text] [Related]
45. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
[TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr virus-positive diffuse large B-cell lymphomas of the elderly.
Adam P; Bonzheim I; Fend F; Quintanilla-Martínez L
Adv Anat Pathol; 2011 Sep; 18(5):349-55. PubMed ID: 21841405
[TBL] [Abstract][Full Text] [Related]
47. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
Latour S; Winter S
Front Immunol; 2018; 9():1103. PubMed ID: 29942301
[TBL] [Abstract][Full Text] [Related]
48. [Clinical and genetic analysis for activated PI3K-δ syndrome by PIK3CD gene mutation].
Liu H; Tang XL; Liu JR; Li HM; Zhao SY
Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):698-702. PubMed ID: 27596086
[TBL] [Abstract][Full Text] [Related]
49. A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus: A case report.
Li GM; Liu HM; Guan WZ; Xu H; Wu BB; Feng JY; Sun L
Medicine (Baltimore); 2019 May; 98(18):e15329. PubMed ID: 31045771
[TBL] [Abstract][Full Text] [Related]
50. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
51. EBV-Related Hodgkin Lymphoma in an ICF2 Patient: Is EBV Susceptibility a Hallmark of This ICF Subtype?
Licciardi F; van den Boogaard M; Delle Piane M; Tovo PA; Montin D
J Clin Immunol; 2019 Apr; 39(3):234-236. PubMed ID: 30719684
[No Abstract] [Full Text] [Related]
52. Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1.
Platt CD; Fried AJ; Hoyos-Bachiloglu R; Usmani GN; Schmidt B; Whangbo J; Chiarle R; Chou J; Geha RS
Clin Immunol; 2017 Oct; 183():142-144. PubMed ID: 28822832
[TBL] [Abstract][Full Text] [Related]
53. A novel splice donor mutation in
Zhang X; Jiang W; Jin Z; Wang X; Song X; Huang S; Zhang M; Lu H
Front Oncol; 2023; 13():1282678. PubMed ID: 37901335
[TBL] [Abstract][Full Text] [Related]
54. A novel human lymphoma cell line (Deglis) with dual B/T phenotype and gene rearrangements and containing Epstein-Barr virus genomes.
al Saati T; Delécluze HJ; Chittal S; Brousset P; Magaud JP; Dastugue N; Cohen-Knafo E; Laurent G; Rubin B; Delsol G
Blood; 1992 Jul; 80(1):209-16. PubMed ID: 1319235
[TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
[TBL] [Abstract][Full Text] [Related]
57. Generation of Epstein-Barr Virus Antigen-Specific T Cell Receptors Recognizing Immunodominant Epitopes of LMP1, LMP2A, and EBNA3C for Immunotherapy.
Dudaniec K; Westendorf K; Nössner E; Uckert W
Hum Gene Ther; 2021 Sep; 32(17-18):919-935. PubMed ID: 33798008
[TBL] [Abstract][Full Text] [Related]
58. Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders.
Shabani M; Nichols KE; Rezaei N
Crit Rev Oncol Hematol; 2016 Dec; 108():109-127. PubMed ID: 27931829
[TBL] [Abstract][Full Text] [Related]
59. Next generation sequencing revealed DNA ligase IV deficiency in a "developmentally normal" patient with massive brain Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Sharapova SO; Chang EY; Guryanova IE; Proleskovskaya IV; Fedorova AS; Rutskaya EA; Aleinikova OV
Clin Immunol; 2016 Feb; 163():108-10. PubMed ID: 26774591
[TBL] [Abstract][Full Text] [Related]
60. A distinctive subgroup of oral EBV+ B-cell neoplasm with polymorphous features is potentially identical to EBV+ mucocutaneous ulcer.
Ohata Y; Tatsuzawa A; Ohyama Y; Ichikawa A; Mochizuki Y; Ishibashi S; Itakura Y; Sakurai U; Sakamoto K; Ikeda T; Kitagawa M; Yamamoto K
Hum Pathol; 2017 Nov; 69():129-139. PubMed ID: 28993276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
